CASH FLOWS FROM OPERATING ACTIVITIES: | |
Net loss from continuing operations | |
Adjustments to reconcile net loss to net cash used for operating activities from continuing operations: | |
Depreciation | 823K |
Share-based compensation expense | 1.74M |
Changes in assets and liabilities: | |
Inventories | 2.34M |
Prepaid expenses and other assets | 4.21M |
Accounts payable | -620K |
Accrued research and clinical expenses | |
Accrued employee compensation and benefits | |
Accrued and other liabilities | -7.23M |
Net cash used for operating activities from continuing operations | 48.59M |
Net cash (used for) provided by operating activities from discontinued operations | |
Net cash used for operating activities | |
CASH FLOWS FROM INVESTING ACTIVITIES: | |
Property and equipment purchases | 0 |
Investment purchases | |
Proceeds from sale/maturity of securities | |
Net cash provided by investing activities from continuing operations | 16.49M |
Net cash used for investing activities from discontinued operations | |
Net cash provided by investing activities | |
CASH FLOWS FROM FINANCING ACTIVITIES: | |
Net proceeds from exercise of common stock options | |
Sale of common stock through employee stock purchase plan | |
Net cash provided by financing activities from continuing operations | -6.33M |
Net cash used for financing activities from discontinued operations | |
Net cash provided by financing activities | |
NET DECREASE IN CASH AND CASH EQUIVALENTS | 58.74M |
CASH AND CASH EQUIVALENTS: | |
Beginning of period | 95.4M |
End of period | 154.14M |